Down 23%, Is It Finally Time to Buy Archer Aviation Stock?

Archer Aviation posted just $300,000 in fourth-quarter sales, up from zero a year earlier, while operating losses widened to nearly $234.4 million as it continued heavy R&D spending. The company still lacks FAA approval for commercial use and may need ongoing equity dilution to fund operations, despite management targeting piloted flights later this year and air taxi service during the 2028 Olympics. The article is broadly cautious on the stock, suggesting investors may want to wait for a better entry point.

Analysis

ACHR is still in the classic pre-revenue trap where the equity behaves more like a long-duration call option than an operating business. The market is increasingly repricing two separate timelines: a near-term dilution and execution overhang versus a much larger but deferred commercialization payoff. That disconnect is why the stock can look cheap on long-term narrative while still underperforming for quarters at a time — until FAA milestones become binary enough to compress the uncertainty discount.

The second-order effect that matters is not just ACHR’s burn, but the beneficiary set around it. STLA’s role reduces manufacturing execution risk and creates a quieter but real industrial option value: if ACHR gains certification traction, suppliers and contract manufacturing ecosystems can monetize volume without taking consumer-demand risk. On the flip side, any delay in certification likely pushes more capital intensity into the ecosystem and favors better-capitalized aviation incumbents and adjacent defense/aerospace names over pure-play eVTOLs.

Consensus seems to underappreciate how equity dilution can cap upside even if the technology roadmap stays intact. With a multi-year runway to meaningful operating revenue, each successive financing round likely shifts the return distribution toward existing downside protection rather than multiple expansion. The stock is therefore more vulnerable to disappointment in guidance than to bad headline numbers; the real catalyst is not a single quarter, but evidence that certification and manufacturing can advance together without forcing a reset of capital needs.

Contrarianly, the selloff may already reflect much of the obvious bad news, but not the hidden positive optionality from a clean certification milestone. If management can show a credible path to piloted flights in the next 6-12 months and maintain liquidity without punitive pricing, the stock could re-rate sharply as the market moves from survival math to adoption math. Until then, the risk/reward still skews better as a trading vehicle around catalysts than as a core fundamental long.

Key Decisions for Investors

• Maintain a tactical underweight/short ACHR into earnings and FAA-driven updates; best risk/reward is on rallies, not weakness, because dilution risk can reassert within 1-2 quarters if progress slips.
• Pair trade: long STLA / short ACHR for 3-6 months. STLA captures manufacturing-adjacent optionality with limited binary risk, while ACHR remains exposed to certification timing and repeated equity issuance.
• For event-driven exposure, buy ACHR call spreads only after confirmed certification or flight-test milestones. Use a 6-12 month horizon to limit theta decay; the trade works only if the market shifts from 'can they survive?' to 'can they scale?'
• Avoid chasing ACHR on headline optimism alone; wait for evidence of lower cash burn or non-dilutive funding. A better entry is after a capital raise or post-earnings selloff, when expectation resets improve asymmetry.
• Relative value lens: prefer established aerospace/defense suppliers over pure-play eVTOL names if seeking urban mobility optionality, as they benefit from program spend without taking the full regulatory/balance-sheet risk.